Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

The biopharma job market failed to turn around in May, but employers were still hiring, especially in Indiana and California, ...

The rehired staff, who number around 460, work with the CDC’s viral disease prevention efforts and sexual health testing labs ...

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

The eight new committee members replace the 17 Kennedy removed earlier this week. In “repopulating” the committee, the HHS ...

BioNTech will get CureVac’s early-stage cancer assets, including its mRNA-based glioblastoma therapy currently in Phase I development. CureVac had previously sued BioNTech for copyright infringement ...